Frederik Marmé

Active 2009–2025

Also published as
Frederik Marmè
133
Papers
19,129
Citations
62
h-index
122
i10-index

Citations

Citations per year for Frederik Marmé1978: 1 citations1992: 1 citations2006: 1 citations2010: 4 citations2011: 15 citations2012: 44 citations2013: 108 citations2014: 162 citations2015: 172 citations2016: 236 citations2017: 207 citations2018: 192 citations2019: 445 citations2020: 690 citations2021: 854 citations2022: 923 citations2023: 874 citations2024: 1,476 citations2025: 771 citations2026: 23 citations1979–1991: no citations, so these years are not shown1993–2005: no citations, so these years are not shown2007–2009: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,120 citing papers, 16% of this breakdownChina: 1,266 citing papers, 9.6% of this breakdownGermany: 909 citing papers, 6.9% of this breakdownUnited Kingdom: 826 citing papers, 6.3% of this breakdownItaly: 756 citing papers, 5.7% of this breakdownFrance: 569 citing papers, 4.3% of this breakdownSpain: 522 citing papers, 3.9% of this breakdownAustralia: 447 citing papers, 3.4% of this breakdownCanada: 438 citing papers, 3.3% of this breakdownNetherlands: 379 citing papers, 2.9% of this breakdownBelgium: 320 citing papers, 2.4% of this breakdownJapan: 300 citing papers, 2.3% of this breakdown
0%16%Other 33%

Fields

  • Medicine61.8%
  • Biochemistry, Genetics and Molecular Biology33.6%
  • Immunology and Microbiology1.8%
  • Engineering0.7%
  • Computer Science0.6%
  • Materials Science0.3%
  • Other1.2%

Topics

  • PARP inhibition in cancer therapy4.6%
  • Peptidase Inhibition and Analysis4.1%
  • BRCA gene mutations in cancer4%
  • HER2/EGFR in Cancer Research4%
  • Ovarian cancer diagnosis and treatment3.8%
  • Breast Cancer Treatment Studies3.7%
  • Other75.8%

Coauthors

All papers

Open in search
  1. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 2,040

  2. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

    Authors: , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2019 cited by 1,446

  3. Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 427

  4. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention

    Authors: , , , , , , , , , , - Journal of Nuclear Medicine 2019 cited by 538

  5. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke and 509 more - Annals of Oncology 2022 cited by 447

  6. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine Seiler, Valentina Nekljudova, Michael Untch, Sibylle Loibl - The Lancet Oncology 2021 cited by 561

  7. A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frederik Marmé, Shannon N. Westin, Iain A. McNeish, Danny Shih, Kevin K. Lin, Sandra Goble, Stephanie Hume, Keiichi Fujiwara, Rebecca Kristeleit - Journal of Clinical Oncology 2022 cited by 384

  8. Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 298

  9. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophie Abadie‐Lacourtoisie, Claudia Andreetta, Nerea Anzizar, Daiseuke Aoki, Maria-Pilar Barretina-Ginesta, Marco Johannes Battista, Charlotte Béllier, Anne Gry Bentzen, Dominique Berton, Bertrand Billemont, Line Bjørge, Maria Bjurberg, Destin Black, Alessandra Bologna, Elena Ioana Braicu, Cláudia Casanova, Radoslav Chekerov, Annick Chevalier, Juan Cueva, Bastian Czogalla, Nicolas Delanoy, Dominik Denschlag, Oscar Derke, Michael Eichbaum, Takayuki Enomoto, Carmen Esteban, Michel Fabbro, Tanja Fehm, Annamaria Ferrero, Markus C. Fleisch, Anne Floquet, Antonio Frassoldati, Lydia Gaba, Angiolo Gadducci, Yolanda García García, Elena Geuna, Eva Guerra, Lars Hanker, Anne‐Claire Hardy‐Bessard, Philipp Harter, Kosei Hasegawa, Kristina Hellman, Ana Herrero, Felix Hilpert, Dionyssios Katsaros, M. Koegel, Anthoula Koliadi, Jean‐Emmanuel Kurtz, Bjoern Lampe, Andrea Alberto Lissoni, Alain Lortholary, Giorgia Mangili, Laura Mansi, Frederik Marmé, Cara Mathews, William Mina, Shinichiro Minobe, Katherine Moxley, Shoji Nagao, Ornella Nicoletto, Koji Nishino, Hiroshi Nishio, Shin Nishio, Ana Oaknin, Michaela Onstad, Beatriz Pardo, José Alejandro Pérez Fidalgo, Carmela Pisano, Andrés Poveda, Julia Caroline Radosa and 21 more - The Lancet 2023 cited by 209

  10. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 324

  11. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Alejandro Pérez Fidalgo, Sandro Pignata, Pedro T. Ramírez, Isabelle Ray‐Coquard, Ignacio Romero, Giovanni Scambia, Jalid Sehouli, Ronnie Shapira‐Frommer, Sudha Sundar, David S.P. Tan, Çağatay Taşkıran, Willemien J. van Driel, Ignace Vergote, François Planchamp, Cristiana Sessa, Anna Fagotti - Annals of Oncology 2024 cited by 284

  12. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2013 cited by 1,040

  13. Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy

    Authors: , , , , , , , , , , - Journal of Nuclear Medicine 2020 cited by 191

  14. Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 cited by 160

  15. Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 cited by 238

  16. TROPiCS-02: A Phase III Study Investigating Sacituzumab Govitecan in the Treatment of HR+/HER2- Metastatic Breast Cancer

    Authors: , , , , , , , , , , , - Future Oncology 2020 cited by 125

  17. Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 cited by 107

  18. LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 cited by 43

  19. Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eveline De Cuypere, Katarzyna Jerzak, Stephen Chia, Maja Maraldo, Jeanette Rønlev, Eva Brix, Minna Tanner, Johanna Mattson, Riikka Huovinen, Pauline Wimberger, Mattea Reinisch, Hans Tesch, Michael Untch, Peter Fasching, Tjoung-Won Park-Simon, Joke Tio, Michael Braun, Eva Maria Grischke, Frederik Marmé, Marion van Mackelenbergh, John McCaffrey, Michelino De Laurentiis, Michele Caruso, Rossana Berardi, Laura Biganzoli, Vittoria Fotia, Toshinari Yamashita, Junji Tsurutani, Koichiro Tsugawa, Nobumoto Tomioka, Maaike de Boer, Daniel Houtsma, Martin Pilskog, Olav Engebråten, Anna Sætersdal, Piotr Wysocki, Zbigniew Nowecki, Barbara Radecka, Jacek Jassem, Renata Duchnowska, Joana Simões, Fatima Cardoso, Ana Rita Sousa, María Jesús Vidal Losada, Cristina Saura Manich, Joaquin Gavilá Gregori, Maria Pilar Lopez Marti, Manuel Ruiz Borrego, Javier Cortés Castán, Rafael López López, César Rodríguez Sanchez, Encarnación González Flores, Carmen Hinojo González, Purificación Martínez del Prado, Aglaia Schiza, Fredrika Killander, Leif Klint, Lorenzo Rossi, Stefan Aebi, Khalil Zaman, Peter Hall, Carey Anders - Nature Medicine 2024 cited by 183

  20. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susana Banerjee, Massimo Barberis, M.P. Barretina Ginesta, J.F. Baurain, Margherita Bignami, Line Bjørge, Paweł Blecharz, Ilan Bruchim, ME Capilna, Nicoletta Cerana, Americo Cicchetti, Dearbhaile Catherine Collins, Nicole Concin, Maurizio D’Incalci, Brittany A. Davidson, Thibault De La Motte Rouge, Pierandrea De Iaco, Fuat Demirkıran, Hannelore Denys, Thilo Doerk, Anne Dørum, Annamaria Ferrero, Alejandro Perez Fidalgo, Maurizio Genuardi, Laurence Gladieff, Rosalind Glasspool, Christoph Grimm, Murat Gültekin, E. Hahnen, Annette Hasenburg, Alinta Hegmane, Viola Heinzelmann, Estrid Høgdall, Ramūnas Janavičius, Sonata Jarmalaitė, Roshni Kalachand, Radka Kaneva, Saadettin Kılıçkap, Roman Kocián, D. Kolencik, Rebecca Kristeleit, Anna Kryzhanivska, Alexandra Léary, Birthe Lemley, Marjolijn J. L. Ligtenberg, José Antonio López‐Guerrero, Christopher J. Lord, E. Åvall‐Lundqvist, Johanna Mäenpää, Sven Mahner, Frederik Marmé, Christian Marth, Iain A. McNeish, Sabine Merkelbach‐Bruse, Marian J.E. Mourits, Nicola Normanno, Ana Oaknin, Kristiina Ojamaa, C. Papdimitriou, F. Penault-Llorca, Anna Myriam Perrone, Sandro Pignata, Eli Pikarsky, Étienne Rouleau, María Jesús Rubio, Anna Sapino, Barbara Schmalfeldt, Jalid Sehouli, Roni Shapira, Karina Dahl Steffensen and 12 more - Annals of Oncology 2021 cited by 164

  21. Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage

    Authors: , , , , , , , , , - Gynecologic Oncology 2011 cited by 304

  22. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanne Meijers‐Heijboer, Muriel A. Adank, Rob B. van der Luijt, Rebecca Hein, Norbert Dahmen, L. Beckman, Alfons Meindl, Rita K. Schmutzler, Bertram Müller‐Myhsok, Peter Lichtner, John L. Hopper, Melissa C. Southey, Enes Makalic, Daniel F. Schmidt, André G. Uitterlinden, Albert Hofman, David J. Hunter, Stephen J. Chanock, Daniel Vincent, François Bacot, Daniel C. Tessier, Sander Canisius, Lodewyk F.A. Wessels, Christopher A. Haiman, Mitul Shah, Robert Luben, Judith Brown, Craig Luccarini, Nils Schoof, Keith Humphreys, Jingmei Li, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Fergus J. Couch, Xianshu Wang, Celine M. Vachon, Kristen N. Stevens, Diether Lambrechts, Matthieu Moisse, Robert Paridaens, Marie‐Rose Christiaens, Anja Rudolph, Stefan Nickels, Dieter Flesch‐Janys, Nichola Johnson, Zoe Aitken, Kirsimari Aaltonen, Tuomas Heikkinen, Annegien Broeks, Laura J. van’t Veer, C. Ellen van der Schoot, Pascal Guénel, Thérèse Truong, Pierre Laurent‐Puig, F. Ménégaux, Frederik Marmé, Andreas Schneeweiß, Christof Sohn, Barbara Burwinkel, M. Pilar Zamora, José Ignacio Arias Pérez, Guillermo Pita, M. Rosario Alonso, Angela Cox, Ian W. Brock, Simon S. Cross, Malcolm Reed, Elinor J. Sawyer, Ian Tomlinson and 122 more - Nature Genetics 2013 cited by 1,105

  23. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Emmanuel Kurtz, Sven Ackermann, C. Anthuber, Mustafa Aydoğdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Ulrich Canzler, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Ahmed El-Balat, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, R. Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Gräfe, Martin Grießhammer, Eva‐Maria Grischke, Isolde Gröll, Martina Gropp‐Meier, Dietrich Hager, Volker Hanf, Carla Hannig, Peer Hantschmann, Philipp Harter, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, T Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon‐Dschun Ko, H. Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, P. Ledwon, Sabine Lemster, B. Lex, Clemens Liebrich, Ralf Lorenz, Hans‐Joachim Lück, Sven� Mahner, Peter Mallmann, Frederik Marmé, Werner Meier, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober and 87 more - The Lancet Oncology 2020 cited by 162

  24. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jenny Chang‐Claude, Dieter Flesch‐Janys, Anja Rudolph, Ursula Eilber, Sabine Behrens, Heli Nevanlinna, Taru Muranen, Kristiina Aittomäki, Carl Blomqvist, Sofia Khan, Kirsimari Aaltonen, Habibul Ahsan, Muhammad G. Kibriya, Alice S. Whittemore, Esther M. John, Kathleen E. Malone, Marilie D. Gammon, Regina M. Santella, Giske Ursin, Enes Makalic, Daniel F. Schmidt, Graham Casey, David J. Hunter, Susan M. Gapstur, Mia M. Gaudet, W. Ryan Diver, Christopher A. Haiman, Fredrick R. Schumacher, Brian E. Henderson, Loı̈c Le Marchand, Christine D. Berg, Stephen J. Chanock, Jonine D. Figueroa, Robert N. Hoover, Diether Lambrechts, Patrick Neven, Hans Wildiers, Erik Van Limbergen, Marjanka K. Schmidt, Annegien Broeks, Senno Verhoef, Sten Cornelissen, Fergus J. Couch, Janet E. Olson, Emily Hallberg, Celine M. Vachon, Quinten Waisfisz, Hanne Meijers‐Heijboer, Muriel A. Adank, Rob B. van der Luijt, Jingmei Li, Jianjun Liu, Keith Humphreys, Daehee Kang, Ji‐Yeob Choi, Sue K. Park, Keun-Young Yoo, Keitaro Matsuo, Hidemi Ito, Hiroji Iwata, Kazuo Tajima, Pascal Guénel, Thérèse Truong, Claire Mulot, Marie Sanchez, Barbara Burwinkel, Frederik Marmé, Harald Surowy, Christof Sohn, Anna H. Wu and 148 more - Nature Genetics 2015 cited by 634